TR201904382T4 - Vajinit tedavisi. - Google Patents
Vajinit tedavisi. Download PDFInfo
- Publication number
- TR201904382T4 TR201904382T4 TR2019/04382T TR201904382T TR201904382T4 TR 201904382 T4 TR201904382 T4 TR 201904382T4 TR 2019/04382 T TR2019/04382 T TR 2019/04382T TR 201904382 T TR201904382 T TR 201904382T TR 201904382 T4 TR201904382 T4 TR 201904382T4
- Authority
- TR
- Turkey
- Prior art keywords
- vaginal
- healthy
- microbiota
- treatment
- vaginitis
- Prior art date
Links
- 201000008100 Vaginitis Diseases 0.000 title abstract 3
- 206010046914 Vaginal infection Diseases 0.000 title abstract 2
- 241000736262 Microbiota Species 0.000 abstract 3
- 239000000126 substance Substances 0.000 abstract 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 abstract 1
- 208000004926 Bacterial Vaginosis Diseases 0.000 abstract 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 208000031888 Mycoses Diseases 0.000 abstract 1
- 208000032159 Vaginal inflammation Diseases 0.000 abstract 1
- 208000037009 Vaginitis bacterial Diseases 0.000 abstract 1
- 239000000443 aerosol Substances 0.000 abstract 1
- JYIBXUUINYLWLR-UHFFFAOYSA-N aluminum;calcium;potassium;silicon;sodium;trihydrate Chemical compound O.O.O.[Na].[Al].[Si].[K].[Ca] JYIBXUUINYLWLR-UHFFFAOYSA-N 0.000 abstract 1
- 229910001603 clinoptilolite Inorganic materials 0.000 abstract 1
- 239000006071 cream Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 229960005309 estradiol Drugs 0.000 abstract 1
- 229930182833 estradiol Natural products 0.000 abstract 1
- 239000000284 extract Substances 0.000 abstract 1
- 239000006260 foam Substances 0.000 abstract 1
- 239000000499 gel Substances 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 235000015097 nutrients Nutrition 0.000 abstract 1
- 239000002674 ointment Substances 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 235000005985 organic acids Nutrition 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- -1 pessary Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 239000000829 suppository Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 208000013464 vaginal disease Diseases 0.000 abstract 1
- 239000000003 vaginal tablet Substances 0.000 abstract 1
- 229940044977 vaginal tablet Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Inorganic Chemistry (AREA)
- Urology & Nephrology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Mevcut buluş, vajinal mikozlar, bakteriyel vajinozis ve vajinitin (vajen iltihabı) diğer formlarının tedavisi ile ilgilidir. Buluşa göre 0,2 ve 10 mm arasında bir partikül boyutuna sahip klinoptilolit, memeliler ve insanların vajinal hastalıklarının tedavisinde dışarıdan kullanıma yönelik ve aynı zamanda sağlıklı vajinal mikrobiyotanın iyileştirilmesine yöneliktir. Buluşa göre madde, aşağıdaki bir veya daha fazla yardımcı madde ile kullanılabilmektedir: farmasötik olarak kabul edilebilir taşıyıcı malzemeler, canlı mikroorganizmalar ve/veya bunların ekstraktları; sağlıklı vajinal mikrobiyotaya yönelik besleyici maddeler (örneğin laktoz vb.); sağlıklı vajinal mikrobiyotaya yönelik vajinal ortamı olumlu şekilde etkileyen maddeler, (örneğin östradiol, organik asitler vb.). Kullanılan bileşim tercihen aşağıdaki bir veya daha fazla uygulama formunda lokal olarak uygulanabilmektedir: köpük, fitil, vajinal tablet, ovül, jel, aerosol, toz, durulama, şırınga, krem/merhem, süspansiyon.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15194288.5A EP3167890A1 (de) | 2015-11-12 | 2015-11-12 | Behandlung von vaginitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201904382T4 true TR201904382T4 (tr) | 2019-04-22 |
Family
ID=54542054
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2019/04382T TR201904382T4 (tr) | 2015-11-12 | 2016-10-25 | Vajinit tedavisi. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20170136060A1 (tr) |
| EP (2) | EP3167890A1 (tr) |
| JP (1) | JP6792420B2 (tr) |
| KR (1) | KR102335607B1 (tr) |
| CN (1) | CN106974932B (tr) |
| AU (1) | AU2016247097B2 (tr) |
| CA (1) | CA2947570C (tr) |
| ES (1) | ES2719223T3 (tr) |
| TR (1) | TR201904382T4 (tr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3524055A1 (de) * | 2018-02-08 | 2019-08-14 | BCSK Biocid GmbH | Antibakterielles und spermizides gleitmittel |
| US20230407365A1 (en) * | 2022-06-21 | 2023-12-21 | Pamela Miles | Diagnostic tool for screening the impact of product ingredients for urogenital microbiomes therapies |
| CN117535208B (zh) * | 2024-01-04 | 2024-03-29 | 四川厌氧生物科技有限责任公司 | 一种卷曲乳杆菌及其在女性生殖道健康中的应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6353146B1 (en) * | 1998-04-20 | 2002-03-05 | Playtex Products, Inc. | Fibrous articles having odor adsorbtion ability and method of making same |
| ES2165139T3 (es) * | 1998-04-30 | 2002-03-01 | Vesely Renata Maria Cavaliere | Composiciones farmaceuticas que contienen lactobacillus brevis y lactobacillus salivarius para el tratamiento de infecciones vaginales. |
| EP1317886B1 (de) * | 1999-04-26 | 2007-06-20 | Tihomir Lelas | Verwendung von mikronisierten Zeolithen als Filterstoffe |
| KR20060128125A (ko) * | 2005-06-09 | 2006-12-14 | 인하대학교 산학협력단 | 만델산을 유효성분으로 함유하는 질염 치료제 |
| BRPI0618529A2 (pt) * | 2005-11-11 | 2011-09-06 | Tihomir Lelas | meio antiviral, abrangendo zeólitos ativados em forma tribomecánica, própolis e colostro |
| EP2040837B1 (de) | 2006-07-04 | 2012-06-20 | Gaston Glock | Verfahren zur schwermetallabtrennung |
| CN101594888A (zh) * | 2006-12-15 | 2009-12-02 | 欧兰益生公司 | 含有产乳酸细菌的吸收制品 |
| WO2009133413A1 (en) * | 2008-04-28 | 2009-11-05 | Novatech D.O.O. | Formulation based on micronized clinoptilolite as a therapeutic agent for removal of toxins, bacteria and viruses from organism |
| US8951549B2 (en) * | 2008-11-21 | 2015-02-10 | Froximun Ag | Method for the reduction of the concentration of amines and salts thereof |
| KR101198572B1 (ko) * | 2010-07-09 | 2012-11-06 | 경희대학교 산학협력단 | 미생물 감염증 치료 또는 개선용 조성물 |
-
2015
- 2015-11-12 EP EP15194288.5A patent/EP3167890A1/de not_active Withdrawn
-
2016
- 2016-10-19 AU AU2016247097A patent/AU2016247097B2/en active Active
- 2016-10-25 EP EP16455004.8A patent/EP3167891B1/de active Active
- 2016-10-25 ES ES16455004T patent/ES2719223T3/es active Active
- 2016-10-25 TR TR2019/04382T patent/TR201904382T4/tr unknown
- 2016-11-03 CA CA2947570A patent/CA2947570C/en active Active
- 2016-11-11 JP JP2016220187A patent/JP6792420B2/ja active Active
- 2016-11-11 US US15/349,727 patent/US20170136060A1/en not_active Abandoned
- 2016-11-11 CN CN201610997927.6A patent/CN106974932B/zh active Active
- 2016-11-14 KR KR1020160151167A patent/KR102335607B1/ko active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| EP3167891A1 (de) | 2017-05-17 |
| AU2016247097A1 (en) | 2017-06-01 |
| AU2016247097B2 (en) | 2021-12-02 |
| CN106974932B (zh) | 2021-05-04 |
| JP6792420B2 (ja) | 2020-11-25 |
| EP3167891B1 (de) | 2019-01-23 |
| CA2947570C (en) | 2021-08-10 |
| CA2947570A1 (en) | 2017-05-12 |
| ES2719223T3 (es) | 2019-07-09 |
| JP2017088603A (ja) | 2017-05-25 |
| BR102016026252A2 (pt) | 2017-05-23 |
| KR102335607B1 (ko) | 2021-12-06 |
| KR20170055932A (ko) | 2017-05-22 |
| US20170136060A1 (en) | 2017-05-18 |
| EP3167890A1 (de) | 2017-05-17 |
| CN106974932A (zh) | 2017-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY196909A (en) | Boronic acid derivatives and therapeutic uses thereof | |
| PH12016500478A1 (en) | Isolated strain of clonostachys rosea for use as a biological control agent | |
| MX2020010412A (es) | Inhibidores de tirosina quinasa de bruton. | |
| PH12016500575A1 (en) | Inhibitors of bruton`s tyrosine kinase | |
| BR112014018728A8 (pt) | Compostos de purinonas como inibidores de quinase | |
| TN2017000554A1 (en) | Novel combination for use in the treatment of cancer | |
| PH12015502535B1 (en) | Process for the preparation of erythrocytes loaded with one or more substances of pharmaceutical interest and so obtained erythrocytes | |
| IN2013MU03583A (tr) | ||
| TR201904382T4 (tr) | Vajinit tedavisi. | |
| MX2022002946A (es) | Inhibidores de cdk y su uso como productos farmaceuticos. | |
| CL2011003327A1 (es) | Composicion farmaceutica que comprende finafloxacina y un agente antiinflamatorio; uso en el tratamiento de infecciones oftalmicas, oticas o nasales. | |
| MX2019008544A (es) | Nueva formulacion estable para anticuerpos anti-fxia. | |
| BR112013033759A8 (pt) | Forma de dosagem unitária de um gel de base aquosa de metronidazol mucoadesivo e uso relacionado ao gel de base aquosa de metronidazol | |
| MX2018002732A (es) | Composicion y dispositivo medico que comprenden acido acetilsalicilico para el tratamiento de infecciones cutaneas por virus de papiloma humano. | |
| PH12017502112A1 (en) | Pyrazole derivatives useful as 5-lipoxygenase activating protein (flap) inhibitors | |
| BR112015014853A2 (pt) | Formulação farmacêutica, formulação farmacêutica liofilizada, uso de uma formulação farmacêutica e artigo de manufatura | |
| PH12015502556A1 (en) | Modified release formulation | |
| CO2020007601A2 (es) | Cepa vacunal de brucella modificada para el tratamiento de brucelosis | |
| BR112018014723A2 (pt) | fantasmas bacterianos para o tratamento de câncer | |
| BR112015027436A2 (en) | Topical composition and carrier for administration of pharmaceutically or cosmetically active ingredients | |
| MX2020006075A (es) | Composiciones farmaceuticas de bendamustina. | |
| BR112015028302A2 (pt) | formulação de pastilha de nicotina | |
| PH12017500323A1 (en) | P38 map kinase inhibiting indanyl urea compounds | |
| MX2019004576A (es) | Composiciones farmaceuticas. | |
| UY39257A (es) | Composición farmacéutica acuosa de levilimab y su uso |